1 asset in Breast Intraductal Proliferative Lesion

Therapeutic assets addressing Breast Intraductal Proliferative Lesion, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Metformin Breast Intraductal Proliferative Lesion	Alliance for Clinical Trials in Oncology	P3	B (60)